FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220852616> ?p ?o ?g. }

• W4220852616 endingPage "101458" @default.
• W4220852616 startingPage "101458" @default.
• W4220852616 abstract "While the combination of Abraxane and gemcitabine (GEM) has been approved as a first-line therapy for the treatment of advanced pancreatic ductal carcinoma (PDAC), the clinical antitumor efficacy is dismal thus far. Here, we explore hyperbaric oxygen (HBO) therapy to boost antitumor efficacy of Abraxane and GEM against murine PDAC Panc02 tumors. Mechanistically, we reveal that HBO significantly constrains cancer-associated fibroblasts (CAFs) by disrupting hypoxia. As CAFs are the main producers of extracellular matrix (ECM) components, HBO effectively reduces collagen Ⅰ and fibronectin, leading to normalization of not only tumor mechanics but also blood vessels. Therefore, HBO augments drug delivery in terms of tumor accumulation, penetration, and cellular internalization. Furthermore, we demonstrate that HBO helps Abraxane and GEM eliminate cancer stem cells (CSCs) by regulating CAFs mediated CSCs niche. Consequently, HBO potentiates antitumor efficacy of Abraxane and GEM by inhibiting not only primary tumors but more importantly metastases of Panc02 tumors, with negligible side effects. Given HBO, Abraxane, and GEM are routinely applied in clinical practice, their combination is readily translatable to bedside applications." @default.
• W4220852616 created "2022-04-03" @default.
• W4220852616 creator A5008079028 @default.
• W4220852616 creator A5010430600 @default.
• W4220852616 creator A5011645302 @default.
• W4220852616 creator A5029849389 @default.
• W4220852616 creator A5030712337 @default.
• W4220852616 creator A5044695121 @default.
• W4220852616 creator A5057751824 @default.
• W4220852616 creator A5067911374 @default.
• W4220852616 creator A5072817423 @default.
• W4220852616 creator A5086232250 @default.
• W4220852616 date "2022-06-01" @default.
• W4220852616 modified "2023-09-30" @default.
• W4220852616 title "Hyperbaric oxygen regulates tumor mechanics and augments Abraxane and gemcitabine antitumor effects against pancreatic ductal adenocarcinoma by inhibiting cancer-associated fibroblasts" @default.
• W4220852616 cites W1976357851 @default.
• W4220852616 cites W2011807945 @default.
• W4220852616 cites W2019264784 @default.
• W4220852616 cites W2028070252 @default.
• W4220852616 cites W2051218702 @default.
• W4220852616 cites W2055091294 @default.
• W4220852616 cites W2059022111 @default.
• W4220852616 cites W2066694851 @default.
• W4220852616 cites W2071123870 @default.
• W4220852616 cites W2072159569 @default.
• W4220852616 cites W2073051356 @default.
• W4220852616 cites W2074495107 @default.
• W4220852616 cites W2084037323 @default.
• W4220852616 cites W2085943887 @default.
• W4220852616 cites W2089294608 @default.
• W4220852616 cites W2095894499 @default.
• W4220852616 cites W2111895881 @default.
• W4220852616 cites W2112514371 @default.
• W4220852616 cites W2127732644 @default.
• W4220852616 cites W2130464657 @default.
• W4220852616 cites W2131170195 @default.
• W4220852616 cites W2137816700 @default.
• W4220852616 cites W2140607197 @default.
• W4220852616 cites W2151253787 @default.
• W4220852616 cites W2165480504 @default.
• W4220852616 cites W2314203153 @default.
• W4220852616 cites W2318567174 @default.
• W4220852616 cites W2325727928 @default.
• W4220852616 cites W2337683177 @default.
• W4220852616 cites W2513294073 @default.
• W4220852616 cites W2517479799 @default.
• W4220852616 cites W2772923107 @default.
• W4220852616 cites W2778271348 @default.
• W4220852616 cites W2781877987 @default.
• W4220852616 cites W2785291766 @default.
• W4220852616 cites W2805079968 @default.
• W4220852616 cites W2809059040 @default.
• W4220852616 cites W2809999850 @default.
• W4220852616 cites W2885761217 @default.
• W4220852616 cites W2909932177 @default.
• W4220852616 cites W2947955936 @default.
• W4220852616 cites W2955641089 @default.
• W4220852616 cites W2989544844 @default.
• W4220852616 cites W2991163352 @default.
• W4220852616 cites W3003058300 @default.
• W4220852616 cites W3007212572 @default.
• W4220852616 cites W3016561671 @default.
• W4220852616 cites W3023906975 @default.
• W4220852616 cites W3023998523 @default.
• W4220852616 cites W3031767666 @default.
• W4220852616 cites W3033089248 @default.
• W4220852616 cites W3042568371 @default.
• W4220852616 cites W3097206347 @default.
• W4220852616 cites W3120831468 @default.
• W4220852616 cites W3127185507 @default.
• W4220852616 cites W3162949857 @default.
• W4220852616 cites W3184144635 @default.
• W4220852616 cites W3198094729 @default.
• W4220852616 cites W3206128638 @default.
• W4220852616 cites W4252082388 @default.
• W4220852616 doi "https://doi.org/10.1016/j.nantod.2022.101458" @default.
• W4220852616 hasPublicationYear "2022" @default.
• W4220852616 type Work @default.
• W4220852616 citedByCount "17" @default.
• W4220852616 countsByYear W42208526162022 @default.
• W4220852616 countsByYear W42208526162023 @default.
• W4220852616 crossrefType "journal-article" @default.
• W4220852616 hasAuthorship W4220852616A5008079028 @default.
• W4220852616 hasAuthorship W4220852616A5010430600 @default.
• W4220852616 hasAuthorship W4220852616A5011645302 @default.
• W4220852616 hasAuthorship W4220852616A5029849389 @default.
• W4220852616 hasAuthorship W4220852616A5030712337 @default.
• W4220852616 hasAuthorship W4220852616A5044695121 @default.
• W4220852616 hasAuthorship W4220852616A5057751824 @default.
• W4220852616 hasAuthorship W4220852616A5067911374 @default.
• W4220852616 hasAuthorship W4220852616A5072817423 @default.
• W4220852616 hasAuthorship W4220852616A5086232250 @default.
• W4220852616 hasConcept C121608353 @default.
• W4220852616 hasConcept C126322002 @default.
• W4220852616 hasConcept C178790620 @default.
• W4220852616 hasConcept C185592680 @default.
• W4220852616 hasConcept C189165786 @default.
• W4220852616 hasConcept C2780210213 @default.

• next